Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HCG Diet Direct was an Arizona-based consumer health company that specialized in the marketing and sale of homeopathic Human Chorionic Gonadotropin (HCG) weight-loss products. The company primarily sold oral drops that were marketed as a solution for rapid weight loss when used in conjunction with a restrictive low-calorie diet. In 2014, the Federal Trade Commission (FTC) took legal action against the company for making deceptive and scientifically unsupported claims regarding the efficacy of its products. Following a settlement with the FTC, which included a significant monetary judgment and prohibitions on future deceptive marketing, the company ceased its primary operations. The FDA has also issued warnings that over-the-counter HCG products for weight loss are illegal and fraudulent.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HCG Diet Direct.